Acute Phase Response After Zoledronic Acid is Associated with Long-Term Effects on White Blood Cells
- 11 June 2013
- journal article
- research article
- Published by Springer Nature in Calcified Tissue International
- Vol. 93 (3) , 249-252
Abstract
We have recently reported a long-lasting decrease in circulating γδ T cells in osteoporotic patients on oral amino-bisphosphonates (N-BPs). Here we verify whether these changes are associated with the occurrence of acute phase response (APR) to intravenous (IV) zoledronic acid (ZOL) or changes of other circulating white blood cells (WBC). WBC count was obtained before and 1 year after a single IV administration of 5 mg ZOL in 36 osteoporotic patients (mean age 72 ± 9, range 45–86 years) without other relevant diseases; 12 of 36 patients developed the classical APR. After 1 year in the patients who experienced an APR, but not in the others, a significant decrease not only of γδ T cells (−30 %), but also of total lymphocytes (−11 %) and eosinophils (−27 %), was observed. The mechanism leading to the observed decrease of circulating lymphocytes and eosinophils remains unclear, but our observation opens a new frontier for the understanding of the immunoeffects of N-BPs.Keywords
This publication has 20 references indexed in Scilit:
- Monocytes and γδ T cells control the acute-phase response to intravenous zoledronate: Insights from a phase IV safety trialJournal of Bone and Mineral Research, 2012
- Long-Term Effects of Amino-Bisphosphonates on Circulating γδ T CellsCalcified Tissue International, 2012
- Can peripheral blood γδ T cells predict osteonecrosis of the jaw? An immunological perspective on the adverse drug effects of aminobisphosphonate therapyJournal of Bone and Mineral Research, 2012
- Circulating γδ T cells and the risk of acute-phase response after zoledronic acid administrationJournal of Bone and Mineral Research, 2011
- γδ T Cells and the Lymphoid Stress-Surveillance ResponseImmunity, 2009
- Peripheral blood monocytes are responsible for γδ T cell activation induced by zoledronic acid through accumulation of IPP/DMAPPBritish Journal of Haematology, 2008
- Essential Requirement of Antigen Presentation by Monocyte Lineage Cells for the Activation of Primary Human γδ T Cells by Aminobisphosphonate AntigenThe Journal of Immunology, 2001
- γ/δ T-Cell Stimulation by PamidronateNew England Journal of Medicine, 1999
- Interleukin-6 and the acute phase response during treatment of patients with paget's disease with the nitrogen-containing bisphosphonate dimethylaminohydroxypropylidene bisphosphonateJournal of Bone and Mineral Research, 1995
- The acute-phase response after bisphosphonate administrationCalcified Tissue International, 1987